Related Experiment Videos
SP-A2 gene expression in human fetal lung airways
K L Goss1, A R Kumar, J M Snyder
1Department of Anatomy and Cell Biology, University of Iowa College of Medicine, Iowa City, Iowa, USA.
American Journal of Respiratory Cell and Molecular Biology
|October 8, 1998
Summary
Surfactant protein (SP)-A messenger RNA (mRNA) was found in the fetal trachea and bronchi, with higher levels in upper airways. SP-A2 mRNA, not SP-A1, is produced in these fetal airway tissues.
Area of Science:
- Pulmonary biology
- Molecular genetics
Background:
- Surfactant protein (SP)-A is crucial for lung function.
- Understanding SP-A expression in fetal airways is important for respiratory health.
Purpose of the Study:
- To characterize surfactant protein (SP)-A messenger RNA (mRNA) expression in the human fetal trachea and bronchi.
- To determine which SP-A subtypes (SP-A1 or SP-A2) are present in these developing airways.
Main Methods:
- Northern blot analysis to detect SP-A mRNA.
- Immunocytochemistry to localize SP-A protein.
- Primer extension analysis to differentiate SP-A1 and SP-A2 mRNA.
- In situ hybridization to localize SP-A mRNA.
Main Results:
- SP-A mRNA was detected in human fetal trachea and bronchi, with levels decreasing in more distal airways.
- SP-A protein was found in airway epithelium and submucosal glands.
- Only SP-A2 mRNA, not SP-A1, was detected in fetal trachea and bronchi.
- SP-A mRNA was abundant in cultured distal fetal lung explants.
Conclusions:
- SP-A2 is the predominant subtype produced in the human fetal tracheal and bronchial epithelium and submucosal glands.
- These findings contribute to understanding fetal lung development and airway immunity.